Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.
about
UK guidelines for the management of bone sarcomasCritical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based researchMethotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good RStereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma.EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatmentPrognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.The efficacy of high-dose versus moderate-dose chemotherapy in treating osteosarcoma: a systematic review and meta-analysisPrimary leiomyosarcoma of bone: analysis of prognosisMifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trialsInvariant NKT cells increase drug-induced osteosarcoma cell death.Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyMelittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model.Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma.Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.A study of 853 high grade osteosarcomas from a single institution-Are outcomes in Indian patients different?An update on chemotherapy for osteosarcoma.A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.Drugs in early clinical development for the treatment of osteosarcoma.Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience.Delay in Diagnosis and Its Effect on Clinical Outcome in High-grade Sarcoma of Bone: A Referral Oncological Centre Study.Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.Risk-Based Therapy for Localized Osteosarcoma.pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials.Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.Primary tumour growth in an orthotopic osteosarcoma mouse model is not influenced by analgesic treatment with buprenorphine and meloxicam.The extremity localized classic osteosarcomas have better survival than the axial non-classics.Osteosarcoma in patients with Rothmund-Thomson syndrome.High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients.
P2860
Q26752425-EB288838-5E07-4FAF-9A88-3FFCF4D192F5Q28484427-F53E4A4B-14A0-4F7E-AE7A-A7602DF27615Q30357731-CF59AECD-A31B-4B66-A445-536E54D16C4CQ34762699-718B0809-C4CB-4653-B60C-43DC61961535Q35005741-144CFF03-484D-4D01-9C8C-5908C24419FBQ35138344-50DCC510-114B-46D1-A710-25DD77016E12Q35619493-5EA639BA-206E-46D3-B416-D9345B4A46F4Q35677274-D2AE13FF-568C-4467-B6F0-DEC15E2CD7FCQ35858388-390C20F3-7A56-47CD-9EF2-9CDE1F6ED2DDQ35897826-91363C91-D0C9-4572-B59A-4223F3770EB7Q35945493-236EDBA7-EC3A-43E2-90D2-E952164D3441Q36327357-811F5F4A-AD41-424E-8955-98714B6630FCQ36446525-FEC449FA-4846-4D64-ACD2-A27798D54056Q36585890-E49699F1-5BBC-4C01-91AA-32CC07C33DDDQ37032307-6BEE67F1-048E-4E53-A586-5EAE555EDC72Q37471124-9CC64D53-B006-46ED-B34A-62CD5CD4E9E3Q37483652-6A89F6C9-60A2-40AF-9AD0-10A6E56A52D0Q37561027-E886C79E-67C2-4CA4-8B3A-F80F43B08732Q37718423-10FC748E-C35D-4FAF-84CF-1059FFC83AEEQ38232992-FAD3EEFE-3DC7-480A-9D08-7DC14569ACF2Q38262894-583D9FBB-604C-471D-A842-A2B760E3F52FQ38588532-E9186A70-C0AA-43BD-B752-AD876D63FDEBQ38612300-55B54D4B-B5B8-4573-922A-F95B34EA7669Q38619114-0A1FC74F-873C-41D6-AB93-EE0984C00727Q38823680-F47CAEE6-BD9F-40C8-AFB1-B72711324471Q38955517-DBC7B3F6-9EFA-45E7-B734-A0881729A297Q39268116-1BD02A36-B28D-4F31-AB34-F279D236A233Q40414026-E07C8A81-6A9A-4A4B-B734-2B44D27D8213Q40664507-D7D40134-241E-42C2-839B-005004FC1BD5Q40769522-C08FBA03-353E-404C-814E-450799196177Q41185936-EF0E4955-3291-45B3-ACD1-8906A79FC5C4Q41533133-D874AE2F-546B-40BF-8504-ADF6F0B12914Q41624093-CCE9374E-5F55-494F-950D-FEDFEEBCCFE5Q43654763-7663BC51-D07B-4FEA-93C7-9C85ABE72DC8Q47687686-964531A0-B111-4EB5-8CFB-A4E83A4C5049Q47752791-8779806D-1562-463E-B830-7FCE228A1166Q50315172-0DC10367-2048-423A-B26D-72EA95527E52Q51065809-465A4676-F484-486A-AD1C-C0683B2C53F3Q55311684-18FD7581-754B-4A30-AF04-67D8B8DA6496
P2860
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Survival from high-grade local ...... randomised controlled trials.
@ast
Survival from high-grade local ...... randomised controlled trials.
@en
type
label
Survival from high-grade local ...... randomised controlled trials.
@ast
Survival from high-grade local ...... randomised controlled trials.
@en
prefLabel
Survival from high-grade local ...... randomised controlled trials.
@ast
Survival from high-grade local ...... randomised controlled trials.
@en
P2093
P2860
P356
P1433
P1476
Survival from high-grade local ...... p randomised controlled trials
@en
P2093
A H M Taminiau
A McTiernan
B Uscinska
H Gelderblom
J S Whelan
M van Glabbeke
P2860
P304
P356
10.1093/ANNONC/MDR491
P577
2011-10-19T00:00:00Z